Abstract:PurposeCancer-related fatigue (CRF) is the most prevalent and distressing symptom among cancer patients and survivors. However, research on its prevalence and related disability in the post-treatment survivorship period remains limited. We sought to describe the occurrence of CRF within three time points in the post-treatment survivorship trajectory.MethodsA self-administered mail-based questionnaire which included the Functional Assessment of Cancer Therapy-Fatigue (FACT-F) and the World Health Organisation Disability Assessment Schedule 2.0 was sent to three cohorts of disease-free breast, prostate or colorectal cancer survivors (6–18 months; 2–3 years; and 5–6 years post-treatment). Clinical information was extracted from chart review. Frequencies of significant fatigue by diagnostic group and time cohorts were studied and compared. Multivariate logistic regressions were conducted to examine the associations between CRF and demographic, clinical, and psychosocial variables.ResultsOne thousand two hundred ninety-four questionnaire packages were returned (63 % response rate). A total of 29 % (95 % CI [27 % to 32 %]) of the sample reported significant fatigue (FACT-F ≤34), and this was associated with much higher levels of disability (p < 0.0001). Breast (40 % [35 % to 44 %]) and colorectal (33 % [27 % to 38 %]) cancer survivors had significantly higher rates of fatigue compared with the prostate group (17 % [14 % to 21 %]) (p < 0.0001). Fatigue levels did not differ between the three time cohorts. The main factors associated with CRF included physical symptom burden, depression, and co-morbidity (AUC, 0.919 [0.903 to 0.936]).ConclusionsClinically relevant levels of CRF are present in approximately 1/3 of cancer survivors up to 6 years post-treatment, and this is associated with high levels of disability.Implications for Cancer SurvivorsClinicians need to be aware of the chronicity of CRF and assess for it routinely in medical practice. While there is no gold standard treatment, non-pharmacological interventions with established efficacy can reduce its severity and possibly minimize its disabling impact on patient functioning. Attention must be paid to the co-occurrence and need for possible treatment of depression and other co-occurring physical symptoms as contributing factors.

Fear of cancer recurrence as a pathway from fatigue to psychological distress in mothers who are breast cancer survivors

Afraid and tired: A longitudinal study of the relationship between cancer‐related fatigue and fear of cancer recurrence in long‐term cancer survivors

Caregiver fear of cancer recurrence: A systematic review and meta‐analysis of quantitative studies

Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study

Fear of cancer recurrence in breast cancer: A moderated serial mediation analysis of a prospective international study.

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis

Predictors and Trajectories of Fear of Cancer Recurrence in Chinese Breast Cancer Patients

Relationship of cancer-related fatigue with psychoneurophysiological (PNP) symptoms in breast cancer survivors

Physiological and psychosocial correlates of cancer-related fatigue

Prevalence and correlates of cancer-related fatigue in breast cancer survivors

Fear of cancer recurrence: A qualitative systematic review and meta-synthesis of patients' experiences

Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients

Fear of the Cancer Coming Back: A Metasynthesis of Fear of Recurrence in Breast Cancer

Cancer-related fatigue and associated disability in post-treatment cancer survivors

Investigating fear of cancer recurrence among female breast cancer survivors and their spouses in southwest China: a cross-sectional study

Core Fear of Cancer recurrence symptoms in Cancer Survivors: a network approach

Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study

Fear of Recurrence Among Lung Cancer Survivors

Social Constraints and Fear of Recurrence among Chinese American Breast Cancer Survivors: an Exploration of Psychosocial Mediators.

Prevalence and Factors Contributing to Fear of Recurrence in Breast Cancer Patients and Their Partners: A Cross-Sectional Study

Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors